The imposition of 100% tariffs on Australian pharmaceuticals has forced CSL to negotiate price reductions in the US market.
Claims
The imposition of 100% tariffs on Australian pharmaceuticals has forced CSL to negotiate price reductions in the US market.
Parent: International TradeEntity: TariffsImpact: negativeDate: Sep 1, 2026Target: The imposition of 100% tariffs on Australian pharmaceuticals
Source posts
CSL signs deal with Trump administration to slash prices for its medicines
www.theage.com.au/business/companies/csl-signs-deal-with-trump-administration-to-slash-prices-for-its-medicines-20260901-p60tdk.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Australia’s largest pharma company has agreed to lower the cost of its medicines in the US as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals.
0 boosts · 0 favs · 0 replies · Sep 1, 2026
CSL signs deal with Trump administration to slash prices for its medicines
www.smh.com.au/business/companies/csl-signs-deal-with-trump-administration-to-slash-prices-for-its-medicines-20260901-p60tdk.html?ref=rss&utm_medium=rss&utm_source=rss_feed
Australia’s largest pharma company has agreed to lower the cost of its medicines in the US as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals.
0 boosts · 0 favs · 0 replies · Sep 1, 2026